COMMUNIQUÉS West-GlobeNewswire

Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products
25/10/2024
CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced it will host a conference call to discuss its Byte Aligner business. Dentsply [...]
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
25/10/2024
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its [...]
International Institute of Infant Sleep is Shaping the Future of Sleep Consulting with Global Education and Affordable Training
25/10/2024
Expanding Access to Sleep Consulting: IIISleep Delivers Comprehensive Education Globally at an Accessible Price Point COPENHAGEN, Denmark, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The International Institute of Infant Sleep ( [...]
Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
25/10/2024
Presentations highlight key preclinical data that support investigational new drug application (IND) submissions for ZW220 in 1H and ZW251 in 2H in 2025 VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- [...]
RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call
25/10/2024
LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma
25/10/2024
First clinical results for RMC-9805, a RAS(ON) G12D-selective inhibitor, demonstrate encouraging tolerability and antitumor activity in patients with PDAC Investor webcast to be held Friday, October 25 at 12:00 p.m. [...]
Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
25/10/2024
Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance Paris, October 25, 2024 Q3 sales growth of 15.7% at CER and business [...]
Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance
25/10/2024
T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance Paris, le 25 [...]
Advanced Care Group Makes a Strong Entrance at Global Health Exhibition, Ready to Lead at Arab Health 2025
25/10/2024
RIYADH, Saudi Arabia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Advanced Care Group is making waves in the Middle Eastern healthcare market following a powerful debut at the Global Health Exhibition in Riyadh. From October 21 [...]
Septerna Prices Upsized Initial Public Offering
25/10/2024
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug [...]
Vision Sensing Acquisition Corp. Announces Securities Suspension Date and Redemption Amount
24/10/2024
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ” or “ VSAC ”), a special purpose acquisition company, announced that Nasdaq will suspend the [...]
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
24/10/2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what [...]
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
24/10/2024
CARSON CITY, Nev., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
The Ensign Group Reports Third Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance
24/10/2024
Conference Call and Webcast scheduled for tomorrow, October 25, 2024 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign( [...]
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
24/10/2024
Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Platform REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic [...]
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
24/10/2024
ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
24/10/2024
WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market opens on Thursday, [...]
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24/10/2024
MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the closing of its [...]
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24/10/2024
Year-over-year revenue grows 11% , operating profit up 34% , non-GAAP operating profit up 27% Operating cash flow of $326 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at [...]

Pages